Our laboratory focuses on two types of early insults to the developing nervous system-- chemical exposures (e.g., lead, elemental mercury, methylmercury, arsenic, manganese, pesticides and anesthetic agents) and insults related to serious medical conditions (e.g., congenital heart lesions, schistosomiasis and congenital diaphragmatic hernia). 

The specific aims of the chemical exposure studies are to: Develop new strategies for quantifying exposure. Define the "behavioral signature," if any, associated with different exposures and exposure scenarios. Identify factors that either increase or decrease an individual's risk associated with exposure to a chemical. The goal of the studies on endogenous insults related to medical conditions is to characterize the associated behavioral risks, particularly risks associated with drug therapies or with invasive interventions, such as procedures to repair serious congenital heart disease. 


David Bellinger has a PhD in Psychology from Cornell University and a Master's degree in Epidemiology from the Harvard School of Public Health. He holds a secondary appointment as Professor in the Department of Environmental Health at the Harvard School of Public Health. He is currently President of the International Society for Children's Health and the Environment.


Publications powered by Harvard Catalyst Profiles

  1. Air pollution and development in Africa: impacts on health, the economy, and human capital. Lancet Planet Health. 2021 Oct; 5(10):e681-e688. View abstract
  2. It's Time to End Lead Poisoning in the United States. JAMA Pediatr. 2021 Sep 27. View abstract
  3. Critical windows of susceptibility in the association between manganese and neurocognition in Italian adolescents living near ferro-manganese industry. Neurotoxicology. 2021 Aug 31; 87:51-61. View abstract
  4. Abnormal Right-Hemispheric Sulcal Patterns Correlate with Executive Function in Adolescents with Tetralogy of Fallot. Cereb Cortex. 2021 Aug 26; 31(10):4670-4680. View abstract
  5. Prenatal PM2.5 exposure in the second and third trimesters predicts neurocognitive performance at age 9-10 years: A cohort study of Mexico City children. Environ Res. 2021 Jul 08; 202:111651. View abstract
  6. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFAS) and child executive function and behavioral problems. Environ Res. 2021 Jul 06; 202:111621. View abstract
  7. Portable HEPA filter air cleaner use during pregnancy and children's behavior problem scores: a secondary analysis of the UGAAR randomized controlled trial. Environ Health. 2021 07 05; 20(1):78. View abstract
  8. Prenatal exposure to a mixture of elements and neurobehavioral outcomes in mid-childhood: Results from Project Viva. Environ Res. 2021 10; 201:111540. View abstract
  9. Executive functions in children with heart disease: a systematic review and meta-analysis. Cardiol Young. 2021 Mar 26; 1-9. View abstract
  10. Performance on the ROCF at 8 Years Predicts Academic Achievement at 16 Years in Individuals with Dextro-Transposition of the Great Arteries. J Int Neuropsychol Soc. 2021 Oct; 27(9):857-864. View abstract
  11. The origins and development of the Cardiac Neurodevelopmental Outcome Collaborative: creating innovative clinical, quality improvement, and research opportunities - Corrigendum. Cardiol Young. 2021 01; 31(1):175. View abstract
  12. Stunting and lead: using causal mediation analysis to better understand how environmental lead exposure affects cognitive outcomes in children. J Neurodev Disord. 2020 12 16; 12(1):39. View abstract
  13. Neurodevelopmental evaluation for school-age children with congenital heart disease: recommendations from the cardiac neurodevelopmental outcome collaborative. Cardiol Young. 2020 Nov; 30(11):1623-1636. View abstract
  14. The origins and development of the cardiac neurodevelopment outcome collaborative: creating innovative clinical, quality improvement, and research opportunities. Cardiol Young. 2020 Nov; 30(11):1597-1602. View abstract
  15. Antenatal Depressive Symptoms and Neurodevelopment Outcomes in Children at 30 Months. A Study From South India. Front Psychiatry. 2020; 11:486175. View abstract
  16. Prenatal PM2.5 exposure and behavioral development in children from Mexico City. Neurotoxicology. 2020 12; 81:109-115. View abstract
  17. Associations of a Metal Mixture Measured in Multiple Biomarkers with IQ: Evidence from Italian Adolescents Living near Ferroalloy Industry. Environ Health Perspect. 2020 09; 128(9):97002. View abstract
  18. Neurocognitive and psychosocial outcomes in adult congenital heart disease: a lifespan approach. Heart. 2021 01; 107(2):159-167. View abstract
  19. Randomized Controlled Trial of Working Memory Intervention in Congenital Heart Disease. J Pediatr. 2020 12; 227:191-198.e3. View abstract
  20. Association of Exposure to Endocrine-Disrupting Chemicals During Adolescence With Attention-Deficit/Hyperactivity Disorder-Related Behaviors. JAMA Netw Open. 2020 08 03; 3(8):e2015041. View abstract
  21. Abnormal Left-Hemispheric Sulcal Patterns Correlate with Neurodevelopmental Outcomes in Subjects with Single Ventricular Congenital Heart Disease. Cereb Cortex. 2020 03 21; 30(2):476-487. View abstract
  22. Parental preconception and prenatal urinary bisphenol A and paraben concentrations and child behavior. Environ Epidemiol. 2020 Feb; 4(1):e082. View abstract
  23. Modification of the effects of prenatal manganese exposure on child neurodevelopment by maternal anemia and iron deficiency. Pediatr Res. 2020 08; 88(2):325-333. View abstract
  24. The Bayley-III scale may underestimate neurodevelopmental disability after cardiac surgery in infants. Eur J Cardiothorac Surg. 2020 01 01; 57(1):63-71. View abstract
  25. Using the delayed spatial alternation task to assess environmentally associated changes in working memory in very young children. Neurotoxicology. 2020 03; 77:71-79. View abstract
  26. In utero exposure to mercury and childhood overweight or obesity: counteracting effect of maternal folate status. BMC Med. 2019 11 28; 17(1):216. View abstract
  27. Time-varying associations between prenatal metal mixtures and rapid visual processing in children. Environ Health. 2019 10 30; 18(1):92. View abstract
  28. Improving and Expanding Estimates of the Global Burden of Disease Due to Environmental Health Risk Factors. Environ Health Perspect. 2019 10; 127(10):105001. View abstract
  29. Behavior and Quality of Life at 6 Years for Children With Hypoplastic Left Heart Syndrome. Pediatrics. 2019 11; 144(5). View abstract
  30. Autism and Congenital Heart Disease: Evidence and Unresolved Questions. Pediatrics. 2019 11; 144(5). View abstract
  31. Early life risk factors of motor, cognitive and language development: a pooled analysis of studies from low/middle-income countries. BMJ Open. 2019 10 03; 9(10):e026449. View abstract
  32. Is Fluoride Potentially Neurotoxic? JAMA Pediatr. 2019 Oct 01; 173(10):915-917. View abstract
  33. Erratum: "Low-Level Environmental Lead Exposure and Children's Intellectual Function: An International Pooled Analysis". Environ Health Perspect. 2019 Sep; 127(9):99001. View abstract
  34. Prenatal lead exposure and childhood executive function and behavioral difficulties in project viva. Neurotoxicology. 2019 12; 75:105-115. View abstract
  35. A benchmark concentration analysis for manganese in drinking water and IQ deficits in children. Environ Int. 2019 09; 130:104889. View abstract
  36. Erratum: Prenatal and Childhood Traffic-Related Pollution Exposure and Childhood Cognition in the Project Viva Cohort (Massachusetts, USA). Environ Health Perspect. 2019 Jun; 127(6):69001. View abstract
  37. Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children. Brain Behav Immun. 2019 08; 80:871-878. View abstract
  38. Failure to validate association of mannose-binding lectin deficiency with adverse neurodevelopmental outcomes after cardiac surgery in infants. J Thorac Cardiovasc Surg. 2019 Jun; 157(6):e397-e398. View abstract
  39. Neurotoxicity of general anesthetics in children: evidence and uncertainties. Curr Opin Pediatr. 2019 04; 31(2):267-273. View abstract
  40. Improving neurodevelopmental outcomes in children with congenital heart disease: protocol for a randomised controlled trial of working memory training. BMJ Open. 2019 02 19; 9(2):e023304. View abstract
  41. Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial. Lancet. 2019 02 16; 393(10172):664-677. View abstract
  42. Effect of Maternal Vitamin B12 Supplementation on Cognitive Outcomes in South Indian Children: A Randomized Controlled Clinical Trial. Matern Child Health J. 2019 Feb; 23(2):155-163. View abstract
  43. Visual-spatial processing style is associated with psychopathology in adolescents with critical congenital heart disease. Clin Neuropsychol. 2019 05; 33(4):760-778. View abstract
  44. Estimates of the 2015 global and regional disease burden from four foodborne metals - arsenic, cadmium, lead and methylmercury. Environ Res. 2019 07; 174:188-194. View abstract
  45. Global burden of intellectual disability resulting from prenatal exposure to methylmercury, 2015. Environ Res. 2019 03; 170:416-421. View abstract
  46. Nutritional, Socioeconomic, and Delivery Characteristics Are Associated with Neurodevelopment in Tanzanian Children. J Pediatr. 2019 04; 207:71-79.e8. View abstract
  47. Retraction notice to "Paraoxonase I polymorphisms and attention/hyperactivity in school-age children from Mexico City, Mexico" Environmental Research (2014) 342 -349. Environ Res. 2018 11; 167:776. View abstract
  48. Longitudinal Associations between Neurodevelopment and Psychosocial Health Status in Patients with Repaired D-Transposition of the Great Arteries. J Pediatr. 2019 01; 204:38-45.e1. View abstract
  49. Concussion History and Cognitive Function in a Large Cohort of Adolescent Athletes. Am J Sports Med. 2018 11; 46(13):3262-3270. View abstract
  50. Bayesian varying coefficient kernel machine regression to assess neurodevelopmental trajectories associated with exposure to complex mixtures. Stat Med. 2018 12 30; 37(30):4680-4694. View abstract
  51. Lead in Air in Bangladesh: Exposure in a Rural Community with Elevated Blood Lead Concentrations among Young Children. Int J Environ Res Public Health. 2018 09 06; 15(9). View abstract
  52. Prenatal lead exposure modifies the association of maternal self-esteem with child adaptive ability. Int J Hyg Environ Health. 2019 01; 222(1):68-75. View abstract
  53. Identification of novel loci associated with infant cognitive ability. Mol Psychiatry. 2020 11; 25(11):3010-3019. View abstract
  54. Growth parameters at birth mediate the relationship between prenatal manganese exposure and cognitive test scores among a cohort of 2- to 3-year-old Bangladeshi children. Int J Epidemiol. 2018 08 01; 47(4):1169-1179. View abstract
  55. Is Dental Amalgam Toxic to Children of Color? J Natl Med Assoc. 2018 Aug; 110(4):414-416. View abstract
  56. Perioperative Exposure to Suspect Neurotoxicants From Medical Devices in Newborns With Congenital Heart Defects. Ann Thorac Surg. 2019 02; 107(2):567-572. View abstract
  57. Iron-processing genotypes, nutrient intakes, and cadmium levels in the Normative Aging Study: Evidence of sensitive subpopulations in cadmium risk assessment. Environ Int. 2018 10; 119:527-535. View abstract
  58. Lagged kernel machine regression for identifying time windows of susceptibility to exposures of complex mixtures. Biostatistics. 2018 07 01; 19(3):325-341. View abstract
  59. Altered White Matter Microstructure Correlates with IQ and Processing Speed in Children and Adolescents Post-Fontan. J Pediatr. 2018 09; 200:140-149.e4. View abstract
  60. Applying methods of the global burden of diseases, injuries, and risk factors study to developmental neurotoxicants: a commentary. Environ Health. 2018 06 04; 17(1):53. View abstract
  61. Markers of Environmental Enteric Dysfunction Are Associated With Neurodevelopmental Outcomes in Tanzanian Children. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):953-959. View abstract
  62. Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition. Environ Int. 2018 06; 115:358-369. View abstract
  63. Lower C-reactive protein and IL-6 associated with vegetarian diets are mediated by BMI. Nutr Metab Cardiovasc Dis. 2018 08; 28(8):787-794. View abstract
  64. n-3 Fatty Acid Supplementation in Mothers, Preterm Infants, and Term Infants and Childhood Psychomotor and Visual Development: A Systematic Review and Meta-Analysis. J Nutr. 2018 03 01; 148(3):409-418. View abstract
  65. Does early vitamin B12 supplementation improve neurodevelopment and cognitive function in childhood and into school age: a study protocol for extended follow-ups from randomised controlled trials in India and Tanzania. BMJ Open. 2018 02 22; 8(2):e018962. View abstract
  66. Announcing the 2018 Toxics Travel Award for Post-Doctoral Fellows. Toxics. 2018 Jan 30; 6(1). View abstract
  67. Blood and Hair Aluminum Levels, Vaccine History, and Early Infant Development: A Cross-Sectional Study. Acad Pediatr. 2018 03; 18(2):161-165. View abstract
  68. Differences in Blood Pressure in Infants After General Anesthesia Compared to Awake Regional Anesthesia (GAS Study-A Prospective Randomized Trial). Anesth Analg. 2017 09; 125(3):837-845. View abstract
  69. Developmental PBDE Exposure and IQ/ADHD in Childhood: A Systematic Review and Meta-analysis. Environ Health Perspect. 2017 08 03; 125(8):086001. View abstract
  70. Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopment. Environ Health. 2017 07 28; 16(1):81. View abstract
  71. Anthropometric measures at birth and early childhood are associated with neurodevelopmental outcomes among Bangladeshi children aged 2-3years. Sci Total Environ. 2017 Dec 31; 607-608:475-482. View abstract
  72. Paternal and maternal preconception urinary phthalate metabolite concentrations and child behavior. Environ Res. 2017 10; 158:720-728. View abstract
  73. Prenatal environmental chemical exposures and longitudinal patterns of child neurobehavior. Neurotoxicology. 2017 Sep; 62:192-199. View abstract
  74. Prenatal co-exposure to manganese and depression and 24-months neurodevelopment. Neurotoxicology. 2018 01; 64:134-141. View abstract
  75. Establishing and Achieving National Goals for Preventing Lead Toxicity and Exposure in Children. JAMA Pediatr. 2017 07 01; 171(7):616-618. View abstract
  76. Maternal and Cord Blood Manganese Concentrations and Early Childhood Neurodevelopment among Residents near a Mining-Impacted Superfund Site. Environ Health Perspect. 2017 06 28; 125(6):067020. View abstract
  77. The Joint Effect of Prenatal Exposure to Metal Mixtures on Neurodevelopmental Outcomes at 20-40 Months of Age: Evidence from Rural Bangladesh. Environ Health Perspect. 2017 06 26; 125(6):067015. View abstract
  78. Learning and Memory in Adolescents With Critical Biventricular Congenital Heart Disease. J Int Neuropsychol Soc. 2017 09; 23(8):627-639. View abstract
  79. Psychiatric Disorders and Function in Adolescents with Tetralogy of Fallot. J Pediatr. 2017 08; 187:165-173. View abstract
  80. Childhood Lead Exposure and Adult Outcomes. JAMA. 2017 03 28; 317(12):1219-1220. View abstract
  81. Neuropsychological and Psychiatric Outcomes in Dextro-Transposition of the Great Arteries across the Lifespan: A State-of-the-Art Review. Front Pediatr. 2017; 5:59. View abstract
  82. Visuospatial processing in adolescents with critical congenital heart disease: Organization, integration, and implications for academic achievement. Child Neuropsychol. 2018 05; 24(4):451-468. View abstract
  83. Development and validation of an early childhood development scale for use in low-resourced settings. Popul Health Metr. 2017 02 09; 15(1):3. View abstract
  84. Psychiatric Disorders in Adolescents With Single Ventricle Congenital Heart Disease. Pediatrics. 2017 Mar; 139(3). View abstract
  85. Prenatal phthalate, triclosan, and bisphenol A exposures and child visual-spatial abilities. Neurotoxicology. 2017 01; 58:75-83. View abstract
  86. Maternal stress modifies the effect of exposure to lead during pregnancy and 24-month old children's neurodevelopment. Environ Int. 2017 Jan; 98:191-197. View abstract
  87. Mechanistic Pathways From Early Gestation Through Infancy and Neurodevelopment. Pediatrics. 2016 12; 138(6). View abstract
  88. White Matter Volume Predicts Language Development in Congenital Heart Disease. J Pediatr. 2017 02; 181:42-48.e2. View abstract
  89. Stunting is associated with blood lead concentration among Bangladeshi children aged 2-3 years. Environ Health. 2016 11 04; 15(1):103. View abstract
  90. Early-Term Birth in Single-Ventricle Congenital Heart Disease After the Fontan Procedure: Neurodevelopmental and Psychiatric Outcomes. J Pediatr. 2016 12; 179:96-103. View abstract
  91. Maternal prenatal fish consumption and cognition in mid childhood: Mercury, fatty acids, and selenium. Neurotoxicol Teratol. 2016 Sep - Oct; 57:71-78. View abstract
  92. Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect. 2016 07 01; 124(7):A118-22. View abstract
  93. Effects of maternal vitamin B12 supplementation on early infant neurocognitive outcomes: a randomized controlled clinical trial. Matern Child Nutr. 2017 04; 13(2). View abstract
  94. Prenatal and childhood traffic-related air pollution exposure and childhood executive function and behavior. Neurotoxicol Teratol. 2016 Sep - Oct; 57:60-70. View abstract
  95. Toddler temperament and prenatal exposure to lead and maternal depression. Environ Health. 2016 06 16; 15(1):71. View abstract
  96. Organizational topology of brain and its relationship to ADHD in adolescents with d-transposition of the great arteries. Brain Behav. 2016 08; 6(8):e00504. View abstract
  97. Association Between a Single General Anesthesia Exposure Before Age 36 Months and Neurocognitive Outcomes in Later Childhood. JAMA. 2016 Jun 07; 315(21):2312-20. View abstract
  98. A developmental perspective on early-life exposure to neurotoxicants. Environ Int. 2016 Sep; 94:103-112. View abstract
  99. The effect of daily zinc and/or multivitamin supplements on early childhood development in Tanzania: results from a randomized controlled trial. Matern Child Nutr. 2017 04; 13(2). View abstract
  100. Processing speed, executive function, and academic achievement in children with dextro-transposition of the great arteries: Testing a longitudinal developmental cascade model. Neuropsychology. 2016 10; 30(7):874-885. View abstract
  101. Neurodevelopmental outcomes among 2- to 3-year-old children in Bangladesh with elevated blood lead and exposure to arsenic and manganese in drinking water. Environ Health. 2016 Mar 12; 15:44. View abstract
  102. Country-specific estimates of the incidence of intellectual disability associated with prenatal exposure to methylmercury. Environ Res. 2016 May; 147:159-63. View abstract
  103. Lead Contamination in Flint--An Abject Failure to Protect Public Health. N Engl J Med. 2016 Mar 24; 374(12):1101-3. View abstract
  104. Prenatal Arsenic Exposure and Birth Outcomes among a Population Residing near a Mining-Related Superfund Site. Environ Health Perspect. 2016 08; 124(8):1308-15. View abstract
  105. Infant Breastfeeding Duration and Mid-Childhood Executive Function, Behavior, and Social-Emotional Development. J Dev Behav Pediatr. 2016 Jan; 37(1):43-52. View abstract
  106. Environment and Brain Development: Challenges in the Global Context. Neuroepidemiology. 2016; 46(2):79-82. View abstract
  107. Neuropsychological Status and Structural Brain Imaging in Adolescents With Single Ventricle Who Underwent the Fontan Procedure. J Am Heart Assoc. 2015 Dec 14; 4(12). View abstract
  108. Neurological and neuropsychological functions in adults with a history of developmental arsenic poisoning from contaminated milk powder. Neurotoxicol Teratol. 2016 Jan-Feb; 53:75-80. View abstract
  109. Methodological Framework for World Health Organization Estimates of the Global Burden of Foodborne Disease. PLoS One. 2015; 10(12):e0142498. View abstract
  110. World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010. PLoS Med. 2015 Dec; 12(12):e1001923. View abstract
  111. World Health Organization estimates of the global and regional disease burden of four foodborne chemical toxins, 2010: a data synthesis. F1000Res. 2015; 4:1393. View abstract
  112. Prenatal particulate air pollution and neurodevelopment in urban children: Examining sensitive windows and sex-specific associations. Environ Int. 2016 Feb; 87:56-65. View abstract
  113. Associations between Prenatal Exposure to Black Carbon and Memory Domains in Urban Children: Modification by Sex and Prenatal Stress. PLoS One. 2015; 10(11):e0142492. View abstract
  114. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet. 2016 Jan 16; 387(10015):239-50. View abstract
  115. Malnutrition and Its Determinants Are Associated with Suboptimal Cognitive, Communication, and Motor Development in Tanzanian Children. J Nutr. 2015 Dec; 145(12):2705-14. View abstract
  116. Life-Long Implications of Developmental Exposure to Environmental Stressors: New Perspectives. Endocrinology. 2015 Oct; 156(10):3408-15. View abstract
  117. Predictors of Failure of Awake Regional Anesthesia for Neonatal Hernia Repair: Data from the General Anesthesia Compared to Spinal Anesthesia Study--Comparing Apnea and Neurodevelopmental Outcomes. Anesthesiology. 2015 Jul; 123(1):55-65. View abstract
  118. Executive function deficits in congenital heart disease: why is intervention important? Cardiol Young. 2015 Oct; 25(7):1238-46. View abstract
  119. Prenatal Lead Exposure Modifies the Impact of Maternal Self-Esteem on Children's Inattention Behavior. J Pediatr. 2015 Aug; 167(2):435-41. View abstract
  120. Comment on "Severe dental fluorosis and cognitive deficits". Neurotoxicol Teratol. 2015 Jul-Aug; 50:32. View abstract
  121. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 2015 May; 135(5):816-25. View abstract
  122. Prenatal and Childhood Traffic-Related Pollution Exposure and Childhood Cognition in the Project Viva Cohort (Massachusetts, USA). Environ Health Perspect. 2015 Oct; 123(10):1072-8. View abstract
  123. Measured Prenatal and Estimated Postnatal Levels of Polychlorinated Biphenyls (PCBs) and ADHD-Related Behaviors in 8-Year-Old Children. Environ Health Perspect. 2015 Sep; 123(9):888-94. View abstract
  124. Relationship of white matter network topology and cognitive outcome in adolescents with d-transposition of the great arteries. Neuroimage Clin. 2015; 7:438-48. View abstract
  125. Of decrements and disorders: assessing impairments in neurodevelopment in prospective studies of environmental toxicant exposures. Environ Health. 2015 Jan 21; 14:8. View abstract
  126. Executive Function in Children and Adolescents with Critical Cyanotic Congenital Heart Disease. J Int Neuropsychol Soc. 2015 Jan; 21(1):34-49. View abstract
  127. Association of lifetime exposure to fluoride and cognitive functions in Chinese children: a pilot study. Neurotoxicol Teratol. 2015 Jan-Feb; 47:96-101. View abstract
  128. Predictors of health-related quality of life in adolescents with tetralogy of Fallot. J Pediatr. 2015 Jan; 166(1):132-8. View abstract
  129. Maternal iron metabolism gene variants modify umbilical cord blood lead levels by gene-environment interaction: a birth cohort study. Environ Health. 2014 Oct 06; 13:77. View abstract
  130. Neurobehavioral function in school-age children exposed to manganese in drinking water. Environ Health Perspect. 2014 Dec; 122(12):1343-50. View abstract
  131. White matter microstructure and cognition in adolescents with congenital heart disease. J Pediatr. 2014 Nov; 165(5):936-44.e1-2. View abstract
  132. Contaminated turmeric is a potential source of lead exposure for children in rural Bangladesh. J Environ Public Health. 2014; 2014:730636. View abstract
  133. Prenatal organochlorine and methylmercury exposure and memory and learning in school-age children in communities near the New Bedford Harbor Superfund site, Massachusetts. Environ Health Perspect. 2014 Nov; 122(11):1253-9. View abstract
  134. Validation of association of the apolipoprotein E e2 allele with neurodevelopmental dysfunction after cardiac surgery in neonates and infants. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2560-6. View abstract
  135. Psychiatric disorders and function in adolescents with d-transposition of the great arteries. J Pediatr. 2014 Oct; 165(4):760-6. View abstract
  136. Factors associated with neurodevelopment for children with single ventricle lesions. J Pediatr. 2014 Sep; 165(3):490-496.e8. View abstract
  137. RETRACTED: Paraoxonase I polymorphisms and attention/hyperactivity in school-age children from Mexico City, Mexico. Environ Res. 2014 07; 132:342-9. View abstract
  138. Cerebral blood flow velocity and neurodevelopmental outcome in infants undergoing surgery for congenital heart disease. Ann Thorac Surg. 2014 Jul; 98(1):125-32. View abstract
  139. Effect of multivitamin supplementation on the neurodevelopment of HIV-exposed Tanzanian infants: a randomized, double-blind, placebo-controlled clinical trial. J Trop Pediatr. 2014 Aug; 60(4):279-86. View abstract
  140. Adolescents with tetralogy of Fallot: neuropsychological assessment and structural brain imaging. Cardiol Young. 2015 Feb; 25(2):338-47. View abstract
  141. Developmental neurotoxicity of ortho-phthalate diesters: review of human and experimental evidence. Neurotoxicology. 2014 Mar; 41:112-22. View abstract
  142. Mercury and pregnancy. Birth Defects Res A Clin Mol Teratol. 2014 Jan; 100(1):1-3. View abstract
  143. Dental sealants and flowable composite restorations and psychosocial, neuropsychological, and physical development in children. Pediatr Dent. 2014 Jan-Feb; 36(1):68-75. View abstract
  144. Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children. Paediatr Perinat Epidemiol. 2014 Mar; 28(2):146-56. View abstract
  145. Infant feeding and childhood cognition at ages 3 and 7 years: Effects of breastfeeding duration and exclusivity. JAMA Pediatr. 2013 Sep; 167(9):836-44. View abstract
  146. Urinary 3,5,6-trichloro-2-pyridinol (TCPY) in pregnant women from Mexico City: distribution, temporal variability, and relationship with child attention and hyperactivity. Int J Hyg Environ Health. 2014 Mar; 217(2-3):405-12. View abstract
  147. Assessment of dietary fish consumption in pregnancy: comparing one-, four- and thirty-six-item questionnaires. Public Health Nutr. 2014 Sep; 17(9):1949-59. View abstract
  148. Perfluorooctanoate and neuropsychological outcomes in children. Epidemiology. 2013 Jul; 24(4):590-9. View abstract
  149. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. JPEN J Parenter Enteral Nutr. 2014 Aug; 38(6):693-701. View abstract
  150. Health risks from lead-based ammunition in the environment. Environ Health Perspect. 2013 Jun; 121(6):A178-9. View abstract
  151. Effect modification by transferrin C2 polymorphism on lead exposure, hemoglobin levels, and IQ. Neurotoxicology. 2013 Sep; 38:17-22. View abstract
  152. Associations between traffic-related black carbon exposure and attention in a prospective birth cohort of urban children. Environ Health Perspect. 2013 Jul; 121(7):859-64. View abstract
  153. A pilot randomized controlled trial to promote healthful fish consumption during pregnancy: the Food for Thought Study. Nutr J. 2013 Mar 15; 12:33. View abstract
  154. Prenatal Exposures to Environmental Chemicals and Children's Neurodevelopment: An Update. Saf Health Work. 2013 Mar; 4(1):1-11. View abstract
  155. Associations between cadmium exposure and neurocognitive test scores in a cross-sectional study of US adults. Environ Health. 2013 Feb 05; 12:13. View abstract
  156. Blood lead level among Palestinian schoolchildren: a pilot study. East Mediterr Health J. 2013 Feb; 19(2):151-5. View abstract
  157. Adolescents with D-transposition of the great arteries repaired in early infancy demonstrate reduced white matter microstructure associated with clinical risk factors. J Thorac Cardiovasc Surg. 2013 Sep; 146(3):543-9.e1. View abstract
  158. Stunting and wasting are associated with poorer psychomotor and mental development in HIV-exposed Tanzanian infants. J Nutr. 2013 Feb; 143(2):204-14. View abstract
  159. Calculation of Mercury's Effects on Neurodevelopment: Bellinger Responds. Environ Health Perspect. 2012 Dec 3; 120(12):a452. View abstract
  160. Prenatal exposure to mercury and fish consumption during pregnancy and attention-deficit/hyperactivity disorder-related behavior in children. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1123-31. View abstract
  161. Feasibility and pilot study of the Pediatric Anesthesia NeuroDevelopment Assessment (PANDA) project. J Neurosurg Anesthesiol. 2012 Oct; 24(4):382-8. View abstract
  162. Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the pediatric heart network infant single ventricle trial. J Pediatr. 2013 Feb; 162(2):250-6.e2. View abstract
  163. An international pooled analysis for obtaining a benchmark dose for environmental lead exposure in children. Risk Anal. 2013 Mar; 33(3):450-61. View abstract
  164. Dental composite restorations and neuropsychological development in children: treatment level analysis from a randomized clinical trial. Neurotoxicology. 2012 Oct; 33(5):1291-7. View abstract
  165. Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association. Circulation. 2012 Aug 28; 126(9):1143-72. View abstract
  166. Dental composite restorations and psychosocial function in children. Pediatrics. 2012 Aug; 130(2):e328-38. View abstract
  167. Predictors of virtual radial arm maze performance in adolescent Italian children. Neurotoxicology. 2012 Oct; 33(5):1203-11. View abstract
  168. Neurotoxic metal coexposures: claus henn et Al. Respond. Environ Health Perspect. 2012 Jun; 120(6):a226-7. View abstract
  169. Assessing windows of susceptibility to lead-induced cognitive deficits in Mexican children. Neurotoxicology. 2012 Oct; 33(5):1040-7. View abstract
  170. Treatment for Schistosoma japonicum, reduction of intestinal parasite load, and cognitive test score improvements in school-aged children. PLoS Negl Trop Dis. 2012; 6(5):e1634. View abstract
  171. Invited commentary. Ann Thorac Surg. 2012 May; 93(5):1583. View abstract
  172. Comparing the population neurodevelopmental burdens associated with children's exposures to environmental chemicals and other risk factors. Neurotoxicology. 2012 Aug; 33(4):641-3. View abstract
  173. Manganese exposure and cognitive deficits: a growing concern for manganese neurotoxicity. Neurotoxicology. 2012 Aug; 33(4):872-80. View abstract
  174. Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation. 2012 May 01; 125(17):2081-91. View abstract
  175. Neuropsychological measures of attention and impulse control among 8-year-old children exposed prenatally to organochlorines. Environ Health Perspect. 2012 Jun; 120(6):904-9. View abstract
  176. Prenatal lead levels, plasma amyloid ß levels, and gene expression in young adulthood. Environ Health Perspect. 2012 May; 120(5):702-7. View abstract
  177. Pre- and postnatal risk factors for ADHD in a nonclinical pediatric population. J Atten Disord. 2013 Jan; 17(1):47-57. View abstract
  178. Cadmium exposure and neurodevelopmental outcomes in U.S. children. Environ Health Perspect. 2012 May; 120(5):758-63. View abstract
  179. Neurobehavioral and neurodevelopmental effects of pesticide exposures. Neurotoxicology. 2012 Aug; 33(4):887-96. View abstract
  180. A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect. 2012 Apr; 120(4):501-7. View abstract
  181. Expanding the scope of risk assessment: methods of studying differential vulnerability and susceptibility. Am J Public Health. 2011 Dec; 101 Suppl 1:S102-9. View abstract
  182. Expanding the scope of environmental risk assessment to better include differential vulnerability and susceptibility. Am J Public Health. 2011 Dec; 101 Suppl 1:S88-93. View abstract
  183. Exploring potential sources of differential vulnerability and susceptibility in risk from environmental hazards to expand the scope of risk assessment. Am J Public Health. 2011 Dec; 101 Suppl 1:S94-101. View abstract
  184. The launch of the International Society for Children's Environmental Health and the Environment (ISCHE). Environ Health Perspect. 2011 Oct; 119(10):A420-1. View abstract
  185. Associations of early childhood manganese and lead coexposure with neurodevelopment. Environ Health Perspect. 2012 Jan; 120(1):126-31. View abstract
  186. Adolescents with d-transposition of the great arteries corrected with the arterial switch procedure: neuropsychological assessment and structural brain imaging. Circulation. 2011 Sep 20; 124(12):1361-9. View abstract
  187. Blood lead levels and cumulative blood lead index (CBLI) as predictors of late neurodevelopment in lead poisoned children. Biomarkers. 2011 Sep; 16(6):517-24. View abstract
  188. Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale. Am Heart J. 2011 Sep; 162(3):425-35.e6. View abstract
  189. The protean toxicities of lead: new chapters in a familiar story. Int J Environ Res Public Health. 2011 07; 8(7):2593-628. View abstract
  190. Learning disability in children as an outcome in anesthesia and analgesia research. Anesth Analg. 2011 Jun; 112(6):1262-4. View abstract
  191. A dopamine receptor (DRD2) but not dopamine transporter (DAT1) gene polymorphism is associated with neurocognitive development of Mexican preschool children with lead exposure. J Pediatr. 2011 Oct; 159(4):638-43. View abstract
  192. Lead exposure and visual-motor abilities in children from Chennai, India. Neurotoxicology. 2011 Aug; 32(4):465-70. View abstract
  193. Low-level environmental lead exposure in childhood and adult intellectual function: a follow-up study. Environ Health. 2011 Mar 30; 10:24. View abstract
  194. Hemoglobin, lead exposure, and intelligence quotient: effect modification by the DRD2 Taq IA polymorphism. Environ Health Perspect. 2011 Jan; 119(1):144-9. View abstract
  195. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ Health Perspect. 2011 Jan; 119(1):138-43. View abstract
  196. Theory of mind deficits in children with congenital heart disease. Dev Med Child Neurol. 2010 Dec; 52(12):1079-80. View abstract
  197. Relationship of intraoperative cerebral oxygen saturation to neurodevelopmental outcome and brain magnetic resonance imaging at 1 year of age in infants undergoing biventricular repair. Circulation. 2010 Jul 20; 122(3):245-54. View abstract
  198. Early postnatal blood manganese levels and children's neurodevelopment. Epidemiology. 2010 Jul; 21(4):433-9. View abstract
  199. Attention-deficit/hyperactivity disorder and urinary metabolites of organophosphate pesticides. Pediatrics. 2010 Jun; 125(6):e1270-7. View abstract
  200. Children's exposure to violence and distress symptoms: influence of caretakers' psychological functioning. Int J Behav Med. 2011 Mar; 18(1):35-43. View abstract
  201. Neurobehavioral deficits and increased blood pressure in school-age children prenatally exposed to pesticides. Environ Health Perspect. 2010 Jun; 118(6):890-6. View abstract
  202. Prenatal organochlorine exposure and behaviors associated with attention deficit hyperactivity disorder in school-aged children. Am J Epidemiol. 2010 Mar 01; 171(5):593-601. View abstract
  203. Blood lead levels and major depressive disorder, panic disorder, and generalized anxiety disorder in US young adults. Arch Gen Psychiatry. 2009 Dec; 66(12):1313-9. View abstract
  204. Anemia of inflammation is related to cognitive impairment among children in Leyte, the Philippines. PLoS Negl Trop Dis. 2009 Oct 20; 3(10):e533. View abstract
  205. Predictors of blood lead in children in Chennai, India (2005-2006). Int J Occup Environ Health. 2009 Oct-Dec; 15(4):351-9. View abstract
  206. Interpreting epidemiologic studies of developmental neurotoxicity: conceptual and analytic issues. Neurotoxicol Teratol. 2009 Sep-Oct; 31(5):267-74. View abstract
  207. Lead exposure and behavior among young children in Chennai, India. Environ Health Perspect. 2009 Oct; 117(10):1607-11. View abstract
  208. Neuropsychological function in school-age children with low mercury exposures. Environ Res. 2009 Aug; 109(6):728-33. View abstract
  209. Subtle hemorrhagic brain injury is associated with neurodevelopmental impairment in infants with repaired congenital heart disease. J Thorac Cardiovasc Surg. 2009 Aug; 138(2):374-81. View abstract
  210. Clinical research approaches to studying pediatric anesthetic neurotoxicity. Neurotoxicology. 2009 Sep; 30(5):766-71. View abstract
  211. Behaviour at eight years in children with surgically corrected transposition: The Boston Circulatory Arrest Trial. Cardiol Young. 2009 Feb; 19(1):86-97. View abstract
  212. Variants in iron metabolism genes predict higher blood lead levels in young children. Environ Health Perspect. 2008 Sep; 116(9):1261-6. View abstract
  213. Associations of maternal fish intake during pregnancy and breastfeeding duration with attainment of developmental milestones in early childhood: a study from the Danish National Birth Cohort. Am J Clin Nutr. 2008 Sep; 88(3):789-96. View abstract
  214. Interaction of the delta-aminolevulinic acid dehydratase polymorphism and lead burden on cognitive function: the VA normative aging study. J Occup Environ Med. 2008 Sep; 50(9):1053-61. View abstract
  215. Neurological and behavioral consequences of childhood lead exposure. PLoS Med. 2008 May 27; 5(5):e115. View abstract
  216. Dental amalgam and psychosocial status: the New England Children's Amalgam Trial. J Dent Res. 2008 May; 87(5):470-4. View abstract
  217. Lead neurotoxicity and socioeconomic status: conceptual and analytical issues. Neurotoxicology. 2008 Sep; 29(5):828-32. View abstract
  218. Neurobehavioral testing in human risk assessment. Neurotoxicology. 2008 May; 29(3):556-67. View abstract
  219. Very low lead exposures and children's neurodevelopment. Curr Opin Pediatr. 2008 Apr; 20(2):172-7. View abstract
  220. Fish consumption, methylmercury and child neurodevelopment. Curr Opin Pediatr. 2008 Apr; 20(2):178-83. View abstract
  221. Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol. 2008 May 15; 167(10):1171-81. View abstract
  222. The faroes statement: human health effects of developmental exposure to chemicals in our environment. Basic Clin Pharmacol Toxicol. 2008 Feb; 102(2):73-5. View abstract
  223. The effect of hematocrit during hypothermic cardiopulmonary bypass in infant heart surgery: results from the combined Boston hematocrit trials. J Thorac Cardiovasc Surg. 2008 Feb; 135(2):355-60. View abstract
  224. Late neurodevelopmental effects of early exposures to chemical contaminants: reducing uncertainty in epidemiological studies. Basic Clin Pharmacol Toxicol. 2008 Feb; 102(2):237-44. View abstract
  225. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery. J Thorac Cardiovasc Surg. 2008 Feb; 135(2):347-54, 354.e1-4. View abstract
  226. Are children with congenital cardiac malformations at increased risk of deficits in social cognition? Cardiol Young. 2008 Feb; 18(1):3-9. View abstract
  227. Maternal self-esteem, exposure to lead, and child neurodevelopment. Neurotoxicology. 2008 Mar; 29(2):278-85. View abstract
  228. Scalp hair and urine mercury content of children in the Northeast United States: the New England Children's Amalgam Trial. Environ Res. 2008 May; 107(1):79-88. View abstract
  229. Lead neurotoxicity in children: decomposing the variability in dose-effect relationships. Am J Ind Med. 2007 Oct; 50(10):720-8. View abstract
  230. Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study. Am J Epidemiol. 2007 Dec 15; 166(12):1400-8. View abstract
  231. A dose-effect analysis of children's exposure to dental amalgam and neuropsychological function: the New England Children's Amalgam Trial. J Am Dent Assoc. 2007 Sep; 138(9):1210-6. View abstract
  232. Neuropsychological function in children with blood lead levels <10 microg/dL. Neurotoxicology. 2007 Nov; 28(6):1170-7. View abstract
  233. Invited commentary: persistent organic pollutants and childhood learning and behavioural disorders. J Epidemiol Community Health. 2007 Jul; 61(7):564-5. View abstract
  234. Update on the clinical management of childhood lead poisoning. Pediatr Clin North Am. 2007 Apr; 54(2):271-94, viii. View abstract
  235. Children's cognitive health: the influence of environmental chemical exposures. Altern Ther Health Med. 2007 Mar-Apr; 13(2):S140-4. View abstract
  236. Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect. 2007 Apr; 115(4):609-15. View abstract
  237. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. Environ Health Perspect. 2007 Jan; 115(1):122-7. View abstract
  238. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect. 2006 Nov; 114(11):1730-5. View abstract
  239. Dental amalgam restorations and children's neuropsychological function: the New England Children's Amalgam Trial. Environ Health Perspect. 2007 Mar; 115(3):440-6. View abstract
  240. A cumulative risk factor model for early identification of academic difficulties in premature and low birth weight infants. Matern Child Health J. 2007 Mar; 11(2):161-72. View abstract
  241. Social ecology of children's vulnerability to environmental pollutants. Environ Health Perspect. 2006 Oct; 114(10):1479-85. View abstract
  242. Longitudinal associations between blood lead concentrations lower than 10 microg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics. 2006 Aug; 118(2):e323-30. View abstract
  243. Delta-aminolevulinic acid dehydratase polymorphism and the relation between low level lead exposure and the Mini-Mental Status Examination in older men: the Normative Aging Study. Occup Environ Med. 2006 Nov; 63(11):746-53. View abstract
  244. Interpretation of small effect sizes in occupational and environmental neurotoxicology: individual versus population risk. Neurotoxicology. 2007 Mar; 28(2):245-51. View abstract
  245. Neuropsychological and renal effects of dental amalgam in children: a randomized clinical trial. JAMA. 2006 Apr 19; 295(15):1775-83. View abstract
  246. Childhood lead poisoning: the torturous path from science to policy. J Clin Invest. 2006 Apr; 116(4):853-7. View abstract
  247. Effect of maternal multivitamin supplementation on the mental and psychomotor development of children who are born to HIV-1-infected mothers in Tanzania. Pediatrics. 2006 Feb; 117(2):e216-25. View abstract
  248. Brain injury in congenital heart disease. Circulation. 2006 Jan 17; 113(2):183-5. View abstract
  249. The timing of mother-to-child transmission of human immunodeficiency virus infection and the neurodevelopment of children in Tanzania. Pediatr Infect Dis J. 2006 Jan; 25(1):47-52. View abstract
  250. Neurotoxicants, Micronutrients, and Social Environments: Individual and Combined Effects on Children's Development. Psychol Sci Public Interest. 2005 Dec; 6(3):57-121. View abstract
  251. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology. 2006 Mar; 27(2):210-6. View abstract
  252. A quantitative analysis of prenatal methyl mercury exposure and cognitive development. Am J Prev Med. 2005 Nov; 29(4):353-65. View abstract
  253. A quantitative risk-benefit analysis of changes in population fish consumption. Am J Prev Med. 2005 Nov; 29(4):325-34. View abstract
  254. A quantitative analysis of prenatal intake of n-3 polyunsaturated fatty acids and cognitive development. Am J Prev Med. 2005 Nov; 29(4):366-74. View abstract
  255. Maternal fish consumption, hair mercury, and infant cognition in a U.S. Cohort. Environ Health Perspect. 2005 Oct; 113(10):1376-80. View abstract
  256. Invited commentary. Ann Thorac Surg. 2005 Sep; 80(3):917. View abstract
  257. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect. 2005 Jul; 113(7):894-9. View abstract
  258. Teratogen update: lead and pregnancy. Birth Defects Res A Clin Mol Teratol. 2005 Jun; 73(6):409-20. View abstract
  259. Helminth infection and cognitive impairment among Filipino children. Am J Trop Med Hyg. 2005 May; 72(5):540-548. View abstract
  260. Prenatal cocaine exposure and children's language functioning at 6 and 9.5 years: moderating effects of child age, birthweight, and gender. J Pediatr Psychol. 2006 Jan-Feb; 31(1):98-115. View abstract
  261. A pilot study of blood lead levels and neurobehavioral function in children living in Chennai, India. Int J Occup Environ Health. 2005 Apr-Jun; 11(2):138-43. View abstract
  262. Protecting children from environmental toxins. PLoS Med. 2005 Mar; 2(3):e61. View abstract
  263. Level of prenatal cocaine exposure and 48-month IQ: importance of preschool enrichment. Neurotoxicol Teratol. 2005 Jan-Feb; 27(1):15-28. View abstract
  264. Prediction of IQ and achievement at age 8 years from neurodevelopmental status at age 1 year in children with D-transposition of the great arteries. Pediatrics. 2004 Nov; 114(5):e572-6. View abstract
  265. Effect of breast milk lead on infant blood lead levels at 1 month of age. Environ Health Perspect. 2004 Oct; 112(14):1381-5. View abstract
  266. Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage. J Trauma. 2004 Jul; 57(1 Suppl):S29-32. View abstract
  267. What is an adverse effect? A possible resolution of clinical and epidemiological perspectives on neurobehavioral toxicity. Environ Res. 2004 Jul; 95(3):394-405. View abstract
  268. Assessing environmental neurotoxicant exposures and child neurobehavior: confounded by confounding? Epidemiology. 2004 Jul; 15(4):383-4. View abstract
  269. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology. 2004 Jun; 100(6):1345-52. View abstract
  270. Lead. Pediatrics. 2004 Apr; 113(4 Suppl):1016-22. View abstract
  271. Effect of prenatal diagnosis on outcomes in D-transposition of the great arteries. Pediatrics. 2004 Apr; 113(4):e335-40. View abstract
  272. Early postoperative body temperature and developmental outcome after open heart surgery in infants. Ann Thorac Surg. 2004 Jan; 77(1):66-71; discussion 71. View abstract
  273. Factors associated with microcephaly at school age in a very-low-birthweight population. Dev Med Child Neurol. 2003 Dec; 45(12):796-801. View abstract
  274. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of a randomized trial in infants. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1765-74. View abstract
  275. Influence of breastfeeding on cognitive outcomes at age 6-8 years: follow-up of very low birth weight infants. Am J Epidemiol. 2003 Dec 01; 158(11):1075-82. View abstract
  276. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003 Nov; 126(5):1397-403. View abstract
  277. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg. 2003 Nov; 126(5):1385-96. View abstract
  278. An approach to assessment of endocrine disruption in the National Children's Study. Environ Health Perspect. 2003 Oct; 111(13):1691-7. View abstract
  279. Neurobehavioral factors associated with referral for learning problems in a community sample: evidence for an adaptational model for learning disorders. J Learn Disabil. 2003 Sep-Oct; 36(5):467-83. View abstract
  280. Apolipoprotein E genotype predicts 24-month bayley scales infant development score. Pediatr Res. 2003 Dec; 54(6):819-25. View abstract
  281. Intellectual impairment and blood lead levels. N Engl J Med. 2003 Jul 31; 349(5):500-2; author reply 500-2. View abstract
  282. Length of stay after infant heart surgery is related to cognitive outcome at age 8 years. J Pediatr. 2003 Jul; 143(1):67-73. View abstract
  283. Initiation of breastfeeding among mothers of very low birth weight infants. Pediatrics. 2003 Jun; 111(6 Pt 1):1337-42. View abstract
  284. Visual-spatial skills in children after open-heart surgery. J Dev Behav Pediatr. 2003 Jun; 24(3):169-79. View abstract
  285. Cardiac surgery and the brain: differences between adult and paediatric studies. Heart. 2003 Apr; 89(4):365-6. View abstract
  286. Motor sequence learning and reading ability: is poor reading associated with sequencing deficits? J Exp Child Psychol. 2003 Apr; 84(4):338-54. View abstract
  287. Perspectives on incorporating human neurobehavioral end points in risk assessments. Risk Anal. 2003 Feb; 23(1):163-74. View abstract
  288. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight. Pediatrics. 2002 Dec; 110(6):1143-52. View abstract
  289. Influence of parental stress and social support on the behavioral adjustment of children with transposition of the great arteries. J Dev Behav Pediatr. 2002 Oct; 23(5):314-21. View abstract
  290. Blood lead level and dental caries in school-age children. Environ Health Perspect. 2002 Oct; 110(10):A625-30. View abstract
  291. Neurodevelopmental outcome after congenital heart surgery: results from an institutional registry. Circulation. 2002 Sep 24; 106(12 Suppl 1):I95-102. View abstract
  292. Information processing deficits in children with attention-deficit/hyperactivity disorder, inattentive type, and children with reading disability. J Learn Disabil. 2002 Sep-Oct; 35(5):448-61. View abstract
  293. Neurologic outcome of choreoathetoid encephalopathy after cardiac surgery. Pediatr Neurol. 2002 Jul; 27(1):9-17. View abstract
  294. Ethical challenges in conducting pediatric environmental health research. Introduction. Neurotoxicol Teratol. 2002 Jul-Aug; 24(4):443. View abstract
  295. Maternal bone lead as an independent risk factor for fetal neurotoxicity: a prospective study. Pediatrics. 2002 Jul; 110(1 Pt 1):110-8. View abstract
  296. A child with chronic manganese exposure from drinking water. Environ Health Perspect. 2002 Jun; 110(6):613-6. View abstract
  297. Perspectives on incorporating human neurobehavioral end points in risk assessments. Risk Anal. 2002 Jun; 22(3):487-98. View abstract
  298. Long-term cognitive benefits of antenatal corticosteroids for prematurely born children with cranial ultrasound abnormalities. Am J Obstet Gynecol. 2002 Apr; 186(4):818-25. View abstract
  299. Narrative discourse in young children with histories of early corrective heart surgery. J Speech Lang Hear Res. 2002 Apr; 45(2):318-31. View abstract
  300. Neurodevelopmental outcomes after biventricular repair of congenital heart defects. J Thorac Cardiovasc Surg. 2002 Apr; 123(4):631-9. View abstract
  301. Future directions for neurobehavioral studies of environmental neurotoxicants. Neurotoxicology. 2001 Oct; 22(5):645-56. View abstract
  302. Neurodevelopmental outcomes in children after the fontan operation. Circulation. 2001 Sep 18; 104(12 Suppl 1):I127-32. View abstract
  303. General health status of children with D-transposition of the great arteries after the arterial switch operation. Circulation. 2001 Sep 18; 104(12 Suppl 1):I138-42. View abstract
  304. Studies of lead exposure and the developing central nervous system: a reply to Kaufman. Arch Clin Neuropsychol. 2001 May; 16(4):359-74. View abstract
  305. Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2001 Feb; 121(2):374-83. View abstract
  306. Children with adequate academic achievement scores referred for evaluation of school difficulties: information processing deficiencies. Dev Neuropsychol. 2001; 20(3):593-603. View abstract
  307. Processing of rapid auditory stimuli in school-age children referred for evaluation of learning disorders. Child Dev. 2001 Jan-Feb; 72(1):37-49. View abstract
  308. Cognitive tests: interpretation for neurotoxicity? (Workshop summary). Toxicol Sci. 2000 Dec; 58(2):222-34. View abstract
  309. Speed of information processing in children referred for learning problems: performance on a visual filtering test. J Learn Disabil. 2000 Nov-Dec; 33(6):538-50. View abstract
  310. Processing speed in children with attention deficit/hyperactivity disorder, inattentive type. Child Neuropsychol. 2000 Sep; 6(3):218-34. View abstract
  311. Cognitive development after the Fontan operation. Circulation. 2000 Aug 22; 102(8):883-9. View abstract
  312. Diminished motor timing control in children referred for diagnosis of learning problems. Dev Neuropsychol. 2000; 17(2):181-97. View abstract
  313. Effect modification in epidemiologic studies of low-level neurotoxicant exposures and health outcomes. Neurotoxicol Teratol. 2000 Jan-Feb; 22(1):133-40. View abstract
  314. Developmental outcome after surgical versus interventional closure of secundum atrial septal defect in children. Circulation. 1999 Nov 09; 100(19 Suppl):II145-50. View abstract
  315. Mother and teacher reports of ADHD symptoms: DSM-IV Questionnaire data. J Am Acad Child Adolesc Psychiatry. 1999 Sep; 38(9):1139-47. View abstract
  316. Developmental and neurological status of children at 4 years of age after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. Circulation. 1999 Aug 03; 100(5):526-32. View abstract
  317. Investigation of the possible associations between fluorosis, fluoride exposure, and childhood behavior problems. Pediatr Dent. 1998 Jul-Aug; 20(4):244-52. View abstract
  318. Relation of seizures after cardiac surgery in early infancy to neurodevelopmental outcome. Boston Circulatory Arrest Study Group. Circulation. 1998 Mar 03; 97(8):773-9. View abstract
  319. Social and economic dimensions of environmental policy: lead poisoning as a case study. Perspect Biol Med. 1998; 41(3):307-26. View abstract
  320. Residential lead-based-paint hazard remediation and soil lead abatement: their impact among children with mildly elevated blood lead levels. Am J Public Health. 1997 Oct; 87(10):1698-702. View abstract
  321. Patterns of developmental dysfunction after surgery during infancy to correct transposition of the great arteries. J Dev Behav Pediatr. 1997 Apr; 18(2):75-83. View abstract
  322. Longitudinal relationship between dentin lead levels in childhood and bone lead levels in young adulthood. Arch Environ Health. 1996 Sep-Oct; 51(5):375-82. View abstract
  323. Biologically based, quantitative risk assessment of neurotoxicants. Fundam Appl Toxicol. 1996 Jan; 29(1):18-30. View abstract
  324. A longitudinal study of chronic lead exposure and physical growth in Boston children. Environ Health Perspect. 1995 Oct; 103(10):952-7. View abstract
  325. Models of delayed recovery. J Child Neurol. 1995 Sep; 10(5):385-91. View abstract
  326. Interpreting the literature on lead and child development: the neglected role of the "experimental system". Neurotoxicol Teratol. 1995 May-Jun; 17(3):201-12. View abstract
  327. von Willebrand factor in plasma, platelets, and selected tissues of ferrets. Lab Anim Sci. 1995 Apr; 45(2):151-9. View abstract
  328. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med. 1995 Mar 02; 332(9):549-55. View abstract
  329. Neuropsychologic function in children exposed to environmental lead. Epidemiology. 1995 Mar; 6(2):101-3. View abstract
  330. The impact of soil lead abatement on urban children's blood lead levels: phase II results from the Boston Lead-In-Soil Demonstration Project. Environ Res. 1994 Nov; 67(2):125-48. View abstract
  331. Low-level lead exposure and cognitive function in children. Pediatr Ann. 1994 Nov; 23(11):600-5. View abstract
  332. Teratogen update: lead. Teratology. 1994 Nov; 50(5):367-73. View abstract
  333. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res. 1994 Jul; 66(1):12-30. View abstract
  334. Attentional correlates of dentin and bone lead levels in adolescents. Arch Environ Health. 1994 Mar-Apr; 49(2):98-105. View abstract
  335. Children with hypoplastic enamel defects of primary incisors are not at increased risk of learning-problem syndromes. ASDC J Dent Child. 1994 Jan-Feb; 61(1):35-8. View abstract
  336. Relationships between serial blood lead levels and exfoliated tooth dentin lead levels: models of tooth lead kinetics. Calcif Tissue Int. 1993 Nov; 53(5):338-41. View abstract
  337. Relation of pH strategy and developmental outcome after hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1993 Aug; 106(2):362-8. View abstract
  338. Epidemiologic approaches to assessing the developmental toxicity of lead. Neurotoxicology. 1993 Summer-Fall; 14(2-3):151-60. View abstract
  339. Lead-contaminated soil abatement and urban children's blood lead levels. JAMA. 1993 Apr 07; 269(13):1647-54. View abstract
  340. Pre- and postnatal low-level lead exposure and children's dysfunction in school. Environ Res. 1993 Jan; 60(1):30-43. View abstract
  341. Neuropsychological correlates of low-level lead exposure in school-age children: a prospective study. Neurotoxicol Teratol. 1993 Jan-Feb; 15(1):27-35. View abstract
  342. The Boston Teacher Questionnaire. 3. A reassessment. J Child Neurol. 1993 Jan; 8(1):64-72. View abstract
  343. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics. 1992 Dec; 90(6):855-61. View abstract
  344. Antecedents and correlates of hypoplastic enamel defects of primary incisors. Pediatr Dent. 1992 May-Jun; 14(3):158-66. View abstract
  345. Pre-natal blood lead levels and learning difficulties in children: an analysis of non-randomly missing categorical data. Stat Med. 1992 Apr; 11(6):799-811. View abstract
  346. The goal: safety and equality. Am J Ind Med. 1992; 21(4):463-5. View abstract
  347. Lead correction. Nature. 1991 Nov 07; 354(6348):26. View abstract
  348. Lead levels among various deciduous tooth types. Bull Environ Contam Toxicol. 1991 Oct; 47(4):602-8. View abstract
  349. Cognitive development of children following early repair of transposition of the great arteries using deep hypothermic circulatory arrest. Pediatrics. 1991 May; 87(5):701-7. View abstract
  350. Weight gain and maturity in fetuses exposed to low levels of lead. Environ Res. 1991 Apr; 54(2):151-8. View abstract
  351. Low-level lead exposure and children's cognitive function in the preschool years. Pediatrics. 1991 Feb; 87(2):219-27. View abstract
  352. The health effects of low level exposure to lead. Annu Rev Public Health. 1991; 12:111-40. View abstract
  353. Antecedents and correlates of improved cognitive performance in children exposed in utero to low levels of lead. Environ Health Perspect. 1990 Nov; 89:5-11. View abstract
  354. Coronary atherosclerosis in the pig. Induced plaque injury and platelet response. Arteriosclerosis. 1990 Jul-Aug; 10(4):541-50. View abstract
  355. Lead and childhood propensity to infectious and allergic disorders: is there an association? Bull Environ Contam Toxicol. 1990 May; 44(5):657-60. View abstract
  356. In utero lead exposure. MCN Am J Matern Child Nurs. 1990 Mar-Apr; 15(2):94-6. View abstract
  357. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. N Engl J Med. 1990 Jan 11; 322(2):83-8. View abstract
  358. Infantile colic and transient developmental lag in the first year of life. Child Psychiatry Hum Dev. 1990; 21(1):25-36. View abstract
  359. Blood lead--tooth lead relationship among Boston children. Bull Environ Contam Toxicol. 1989 Oct; 43(4):485-92. View abstract
  360. Lead, IQ and social class. Int J Epidemiol. 1989 Mar; 18(1):180-5. View abstract
  361. Prenatal/early postnatal exposure to lead and risk of developmental impairment. Birth Defects Orig Artic Ser. 1989; 25(6):73-97. View abstract
  362. Soil lead-blood lead relationship among Boston children. Bull Environ Contam Toxicol. 1988 Dec; 41(6):791-7. View abstract
  363. Low-level lead exposure, social class, and infant development. Neurotoxicol Teratol. 1988 Nov-Dec; 10(6):497-503. View abstract
  364. Recent developments: UAW vs Johnson control. Environ Res. 1988 Aug; 46(2):190-1. View abstract
  365. Pregnancy hypertension, blood pressure during labor, and blood lead levels. Hypertension. 1987 Oct; 10(4):447-51. View abstract
  366. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med. 1987 Apr 23; 316(17):1037-43. View abstract
  367. Correlates of low-level lead exposure in urban children at 2 years of age. Pediatrics. 1986 Jun; 77(6):826-33. View abstract
  368. Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol. 1986 Mar-Apr; 8(2):151-61. View abstract
  369. Consequences of unremitting middle-ear infection in early life. N Engl J Med. 1985 Nov 21; 313(21):1353-4. View abstract
  370. Environmental correlates of infant blood lead levels in Boston. Environ Res. 1985 Oct; 38(1):96-107. View abstract
  371. Methodological issues in modeling the relationship between low-level lead exposure and infant development: examples from the Boston Lead Study. Environ Res. 1985 Oct; 38(1):119-29. View abstract
  372. Home refinishing, lead paint, and infant blood lead levels. Am J Public Health. 1985 Apr; 75(4):403-4. View abstract
  373. Early sensory-motor development and prenatal exposure to lead. Neurobehav Toxicol Teratol. 1984 Sep-Oct; 6(5):387-402. View abstract
  374. A followup study of the academic attainment and classroom behavior of children with elevated dentine lead levels. Biol Trace Elem Res. 1984 Jun; 6(3):207-23. View abstract
  375. Lead and the relationship between maternal and child intelligence. J Pediatr. 1983 Apr; 102(4):523-7. View abstract
  376. Lead-associated intellectual deficit. N Engl J Med. 1982 Feb 11; 306(6):367. View abstract
  377. Does lead at low dose affect intelligence in children? Pediatrics. 1981 Dec; 68(6):894-6. View abstract
  378. The epidemiology of low-level lead exposure in childhood. J Am Acad Child Psychiatry. 1981; 20(3):496-512. View abstract
  379. Consistency in the pattern of change in mothers' speech: some discriminant analyses. J Child Lang. 1980 Oct; 7(3):469-87. View abstract
  380. Changes in the explicitness of mothers' directives as children age. J Child Lang. 1979 Oct; 6(3):443-58. View abstract